BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McCarthy AR, Pirrie L, Hollick JJ, Ronseaux S, Campbell J, Higgins M, Staples OD, Tran F, Slawin AM, Lain S, Westwood NJ. Synthesis and biological characterisation of sirtuin inhibitors based on the tenovins. Bioorg Med Chem 2012;20:1779-93. [PMID: 22304848 DOI: 10.1016/j.bmc.2012.01.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhao X, Zhu C, Li H, Yang Y, Roesky HW. Synthesis and Characterization of Copper(I) Halide Complexes with N -(2, 6-Diisopropylphenyl)- N ′-benzoylthiourea: Monomeric, Dimeric, and Cage Structures: Copper(I) Halide Complexes with N -(2, 6-Diisopropylphenyl)- N ′-benzoylthiourea. Z anorg allg Chem 2014;640:1614-21. [DOI: 10.1002/zaac.201400079] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.9] [Reference Citation Analysis]
2 Koca İ, Özgür A, Coşkun KA, Tutar Y. Synthesis and anticancer activity of acyl thioureas bearing pyrazole moiety. Bioorg Med Chem 2013;21:3859-65. [PMID: 23664495 DOI: 10.1016/j.bmc.2013.04.021] [Cited by in Crossref: 114] [Cited by in F6Publishing: 88] [Article Influence: 12.7] [Reference Citation Analysis]
3 Yuan H, He M, Cheng F, Bai R, da Silva SR, Aguiar RC, Gao SJ. Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy. Oncotarget 2017;8:14912-24. [PMID: 28118604 DOI: 10.18632/oncotarget.14741] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
4 Wu S, Zhao X, Li H, Yang Y, Roesky HW. Synthesis and Characterization of N , N -Di-substituted Acylthiourea Copper(II) Complexes: N , N -Di-substituted Acylthiourea Copper(II) Complexes. Z anorg allg Chem 2015;641:883-9. [DOI: 10.1002/zaac.201400605] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Groves MJ, Johnson CE, James J, Prescott AR, Cunningham J, Haydock S, Pepper C, Fegan C, Pirrie L, Westwood NJ, Coates PJ, Ganley IG, Tauro S. p53 and cell cycle independent dysregulation of autophagy in chronic lymphocytic leukaemia. Br J Cancer 2013;109:2434-44. [PMID: 24091621 DOI: 10.1038/bjc.2013.601] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
6 Ladds MJGW, Pastor-Fernández A, Popova G, van Leeuwen IMM, Eng KE, Drummond CJ, Johansson L, Svensson R, Westwood NJ, McCarthy AR, Tholander F, Popa M, Lane DP, McCormack E, McInerney GM, Bhatia R, Laín S. Autophagic flux blockage by accumulation of weakly basic tenovins leads to elimination of B-Raf mutant tumour cells that survive vemurafenib. PLoS One 2018;13:e0195956. [PMID: 29684045 DOI: 10.1371/journal.pone.0195956] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Garcia-Peterson LM, Li X. Trending topics of SIRT1 in tumorigenicity. Biochim Biophys Acta Gen Subj 2021;1865:129952. [PMID: 34147543 DOI: 10.1016/j.bbagen.2021.129952] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Mellini P, Carafa V, Di rienzo B, Rotili D, De vita D, Cirilli R, Gallinella B, Provvisiero DP, Di maro S, Novellino E, Altucci L, Mai A. Carprofen Analogues as Sirtuin Inhibitors: Enzyme and Cellular Studies. ChemMedChem 2012;7:1905-8. [DOI: 10.1002/cmdc.201200318] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ladds MJGW, Popova G, Pastor-Fernández A, Kannan S, van Leeuwen IMM, Håkansson M, Walse B, Tholander F, Bhatia R, Verma CS, Lane DP, Laín S. Exploitation of dihydroorotate dehydrogenase (DHODH) and p53 activation as therapeutic targets: A case study in polypharmacology. J Biol Chem 2020;295:17935-49. [PMID: 32900849 DOI: 10.1074/jbc.RA119.012056] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Villalba JM, Alcaín FJ. Sirtuin activators and inhibitors. Biofactors 2012;38:349-59. [PMID: 22730114 DOI: 10.1002/biof.1032] [Cited by in Crossref: 197] [Cited by in F6Publishing: 184] [Article Influence: 19.7] [Reference Citation Analysis]
11 Mellini P, Itoh Y, Elboray EE, Tsumoto H, Li Y, Suzuki M, Takahashi Y, Tojo T, Kurohara T, Miyake Y, Miura Y, Kitao Y, Kotoku M, Iida T, Suzuki T. Identification of Diketopiperazine-Containing 2-Anilinobenzamides as Potent Sirtuin 2 (SIRT2)-Selective Inhibitors Targeting the "Selectivity Pocket", Substrate-Binding Site, and NAD+-Binding Site. J Med Chem 2019;62:5844-62. [PMID: 31144814 DOI: 10.1021/acs.jmedchem.9b00255] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
12 Sun Y, Zhou H, Zhu H, Leung SW. Ligand-based virtual screening and inductive learning for identification of SIRT1 inhibitors in natural products. Sci Rep 2016;6:19312. [PMID: 26805727 DOI: 10.1038/srep19312] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
13 Ke X, Qin Q, Deng T, Liao Y, Gao SJ. Heterogeneous Responses of Gastric Cancer Cell Lines to Tenovin-6 and Synergistic Effect with Chloroquine. Cancers (Basel) 2020;12:E365. [PMID: 32033497 DOI: 10.3390/cancers12020365] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
14 Schiedel M, Robaa D, Rumpf T, Sippl W, Jung M. The Current State of NAD+ -Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets. Med Res Rev 2018;38:147-200. [PMID: 28094444 DOI: 10.1002/med.21436] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 12.0] [Reference Citation Analysis]
15 Yoon YK, Choon TS. Structural Modifications of Benzimidazoles via Multi-Step Synthesis and Their Impact on Sirtuin-Inhibitory Activity: Structurally Modified Benzimidazoles as Sirtuin Inhibitors. Arch Pharm Chem Life Sci 2016;349:1-8. [DOI: 10.1002/ardp.201500337] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
16 Cui H, Kamal Z, Ai T, Xu Y, More SS, Wilson DJ, Chen L. Discovery of potent and selective sirtuin 2 (SIRT2) inhibitors using a fragment-based approach. J Med Chem 2014;57:8340-57. [PMID: 25275824 DOI: 10.1021/jm500777s] [Cited by in Crossref: 59] [Cited by in F6Publishing: 50] [Article Influence: 7.4] [Reference Citation Analysis]
17 Sinha S, Sharma S, Vora J, Shrivastava N. Emerging role of sirtuins in breast cancer metastasis and multidrug resistance: Implication for novel therapeutic strategies targeting sirtuins. Pharmacol Res 2020;158:104880. [PMID: 32442721 DOI: 10.1016/j.phrs.2020.104880] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Mellini P, Itoh Y, Tsumoto H, Li Y, Suzuki M, Tokuda N, Kakizawa T, Miura Y, Takeuchi J, Lahtela-Kakkonen M, Suzuki T. Potent mechanism-based sirtuin-2-selective inhibition by an in situ-generated occupant of the substrate-binding site, "selectivity pocket" and NAD+-binding site. Chem Sci 2017;8:6400-8. [PMID: 28989670 DOI: 10.1039/c7sc02738a] [Cited by in Crossref: 34] [Cited by in F6Publishing: 13] [Article Influence: 6.8] [Reference Citation Analysis]
19 Silva JL, Lima CGS, Rangel LP, Ferretti GDS, Pauli FP, Ribeiro RCB, da Silva TB, da Silva FC, Ferreira VF. Recent Synthetic Approaches towards Small Molecule Reactivators of p53. Biomolecules 2020;10:E635. [PMID: 32326087 DOI: 10.3390/biom10040635] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
20 Ali I, Conrad RJ, Verdin E, Ott M. Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics. Chem Rev 2018;118:1216-52. [PMID: 29405707 DOI: 10.1021/acs.chemrev.7b00181] [Cited by in Crossref: 107] [Cited by in F6Publishing: 108] [Article Influence: 26.8] [Reference Citation Analysis]
21 Ružić D, Đoković N, Nikolić K, Vujić Z. Medicinal chemistry of histone deacetylase inhibitors. Arhiv za farmaciju 2021;71:73-100. [DOI: 10.5937/arhfarm71-30618] [Reference Citation Analysis]
22 Khosravi Y, Dieye Y, Loke MF, Goh KL, Vadivelu J. Streptococcus mitis induces conversion of Helicobacter pylori to coccoid cells during co-culture in vitro. PLoS One. 2014;9:e112214. [PMID: 25386948 DOI: 10.1371/journal.pone.0112214] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.5] [Reference Citation Analysis]
23 Nitulescu GM, Draghici C, Olaru OT, Matei L, Ioana A, Dragu LD, Bleotu C. Synthesis and apoptotic activity of new pyrazole derivatives in cancer cell lines. Bioorg Med Chem 2015;23:5799-808. [PMID: 26193760 DOI: 10.1016/j.bmc.2015.07.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
24 Pirrie L, McCarthy AR, Major LL, Morkūnaitė V, Zubrienė A, Matulis D, Lain S, Lebl T, Westwood NJ. Discovery and validation of SIRT2 inhibitors based on tenovin-6: use of a ¹H-NMR method to assess deacetylase activity. Molecules 2012;17:12206-24. [PMID: 23079492 DOI: 10.3390/molecules171012206] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
25 Lei H, Yang Y, Li C, Jia F, Jiang N, Gong P, Zhai X. Catalyst-Free Cyclization- and Curtius Rearrangement-Induced Functional Group Transformation: An Improved Synthetic Strategy of First-in-Class ATX Inhibitor Ziritaxestat (GLPG-1690). Org Process Res Dev 2020;24:997-1005. [DOI: 10.1021/acs.oprd.9b00511] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
26 Hong JY, Lin H. Sirtuin Modulators in Cellular and Animal Models of Human Diseases. Front Pharmacol 2021;12:735044. [PMID: 34650436 DOI: 10.3389/fphar.2021.735044] [Reference Citation Analysis]
27 MacCallum SF, Groves MJ, James J, Murray K, Appleyard V, Prescott AR, Drbal AA, Nicolaou A, Cunningham J, Haydock S, Ganley IG, Westwood NJ, Coates PJ, Lain S, Tauro S. Dysregulation of autophagy in chronic lymphocytic leukemia with the small-molecule Sirtuin inhibitor Tenovin-6. Sci Rep 2013;3:1275. [PMID: 23429453 DOI: 10.1038/srep01275] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 3.1] [Reference Citation Analysis]
28 Hu J, Jing H, Lin H. Sirtuin inhibitors as anticancer agents. Future Med Chem 2014;6:945-66. [PMID: 24962284 DOI: 10.4155/fmc.14.44] [Cited by in Crossref: 96] [Cited by in F6Publishing: 82] [Article Influence: 13.7] [Reference Citation Analysis]
29 Ai T, Wilson DJ, More SS, Xie J, Chen L. 5-((3-Amidobenzyl)oxy)nicotinamides as Sirtuin 2 Inhibitors. J Med Chem 2016;59:2928-41. [PMID: 26982234 DOI: 10.1021/acs.jmedchem.5b01376] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
30 Yuan H, Tan B, Gao SJ. Tenovin-6 impairs autophagy by inhibiting autophagic flux. Cell Death Dis 2017;8:e2608. [PMID: 28182004 DOI: 10.1038/cddis.2017.25] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
31 Yoon YK, Ali MA, Wei AC, Choon TS, Shirazi AN, Parang K. Discovery of a potent and highly fluorescent sirtuin inhibitor. Med Chem Commun 2015;6:1857-63. [DOI: 10.1039/c5md00307e] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
32 Kupis W, Pałyga J, Tomal E, Niewiadomska E. The role of sirtuins in cellular homeostasis. J Physiol Biochem 2016;72:371-80. [PMID: 27154583 DOI: 10.1007/s13105-016-0492-6] [Cited by in Crossref: 80] [Cited by in F6Publishing: 81] [Article Influence: 13.3] [Reference Citation Analysis]